Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05122247 · ClinicalTrials.gov registry record
Machine Learning to Predict Acute Care During Cancer Therapy
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 12,000
- Enrollment target
NCT05122247 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 12,000 participants.
The verdict
NCT05122247 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 12,000 participants
- Enrollment target
Study Summary
The objective of this study is to apply a validated machine-learning based model (SHIELD-RT, NCT04277650) to a cohort of patients undergoing systemic therapy as outpatient cancer treatment to generate an automatic system for the prediction of unplanned hospital admission rates and emergency department encounters.
Interventions
- OTHER Machine learning algorithm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12,000 participants |
| Start Date | 2022-01-03 |
| Est. Completion | 2023-09-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05122247
The ClinicalTrials.gov registry entry for NCT05122247 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Machine learning algorithm is the first listed.
NCT05122247 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05122247 about?
NCT05122247 is a clinical study titled "Machine Learning to Predict Acute Care During Cancer Therapy". The objective of this study is to apply a validated machine-learning based model (SHIELD-RT, NCT04277650) to a cohort of patients undergoing systemic therapy as outpatient cancer treatment to generate an automatic system for the prediction of unplanned hospital admission rates and emergency departme...
What is the current status of trial NCT05122247?
This trial is currently completed. The enrollment target is 12,000 participants. The study started on 2022-01-03. Estimated completion is 2023-09-19.
What interventions are being tested in trial NCT05122247?
The interventions under investigation include: Machine learning algorithm (OTHER).
Who is sponsoring clinical trial NCT05122247?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.